S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer

from OncLive® On Air · host OncLive® On Air

Dr Gilbert discusses the FDA approval of dostarlimab in patients with endometrial cancer, key efficacy data from the GARNET trial, and how this agent bolsters the endometrial cancer treatment paradigm.

Episode metadata supplied by the publisher feed · Published Apr 13, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer

0:00 13:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncLive® On Air?

This episode is 13 minutes long.

When was this OncLive® On Air episode published?

This episode was published on April 13, 2023.

Can I download this OncLive® On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!